Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Other Unique Bacteria01:18

Other Unique Bacteria

434
Magnetic bacteria exhibit a directed movement called magnetotaxis, driven by structures called magnetosomes. These magnetosomes consist of chains of magnetic particles made of either magnetite (Fe₃O₄) or greigite (Fe₃S₄) and are organized in a linear conformation by a protein scaffold within invaginations of the cell membrane. The bacteria align along the north–south magnetic field lines, much like a compass needle. They are typically microaerophilic or anaerobic...
434
Second Uniqueness Theorem01:16

Second Uniqueness Theorem

2.6K
Consider a region consisting of several individual conductors with a definite charge density in the region between these conductors. The second uniqueness theorem states that if the total charge on each conductor and the charge density in the in-between region are known, then the electric field can be uniquely determined.
In contrast, consider that the electric field is non-unique and apply Gauss's law in divergence form in the region between the conductors and the integral form to the surface...
2.6K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

538
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
538
Inflammatory Response01:28

Inflammatory Response

16.6K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.6K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

7.7K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
7.7K
Subviral Agents01:29

Subviral Agents

556
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
556

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of Recall Among Plastic Surgery Devices Cleared Through the FDA 510(k) Pathway.

Aesthetic surgery journal. Open forum·2026
Same author

Extending the Private Equity Conversation in Aesthetic Surgery.

Aesthetic surgery journal·2026
Same author

Commercial Price Variation for Common Dermatologic Procedures.

JAMA dermatology·2026
Same author

Lung-specific sulfonium lipid nanoparticle formulation of dexamethasone suppresses endotoxin-induced lung inflammation.

Frontiers in immunology·2026
Same author

Evaluation of the bioassay for detecting early endothelial activation using microvascular cultures in renal transplant recipients.

Transplant immunology·2026
Same author

Telodendrimer nanotrap for selective cytokine removal from sepsis patient plasma.

Frontiers in immunology·2026

Related Experiment Video

Updated: Jan 28, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
08:27

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

8.1K

Sparstolonin B: A Unique Anti-Inflammatory Agent.

Natesh Yepuri1, Ravi Dhawan, Mitchell Cooney

  • 1Department of Surgery, SUNY Upstate Medical University, Syracuse, New York.

Shock (Augusta, Ga.)
|February 27, 2019
PubMed
Summary

Sparstolonin B, derived from a Chinese herb, shows promise in treating inflammatory diseases by selectively suppressing Toll-like receptors (TLRs). This review highlights its potential therapeutic applications for TLR-mediated disorders.

More Related Videos

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.0K
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.0K

Related Experiment Videos

Last Updated: Jan 28, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
08:27

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

8.1K
Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.0K
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.0K

Area of Science:

  • Immunology
  • Pharmacology
  • Natural Products

Background:

  • Toll-like receptors (TLRs) are crucial transmembrane proteins involved in sensing pathogens and initiating inflammatory responses.
  • Dysregulated TLR signaling is implicated in various diseases, driving the search for effective therapeutic antagonists.
  • Sparstolonin B, a natural compound, has emerged as a selective TLR suppressor with potential anti-inflammatory properties.

Purpose of the Study:

  • To review the existing literature on Sparstolonin B's efficacy in vitro and in vivo inflammatory models.
  • To provide an overview of Sparstolonin B's potential applications in diverse inflammatory diseases.
  • To summarize the role of TLRs in inflammation and current TLR antagonist strategies.

Main Methods:

  • Literature review of in vitro and in vivo studies involving Sparstolonin B.
  • Analysis of Sparstolonin B's mechanism of action on Toll-like receptors.
  • Synthesis of data on TLRs' role in various inflammatory conditions.

Main Results:

  • Sparstolonin B demonstrates selective suppression of Toll-like receptor signaling.
  • Studies indicate Sparstolonin B's effectiveness across various inflammatory models.
  • The compound exhibits potential as a therapeutic agent for TLR-mediated inflammation.

Conclusions:

  • Sparstolonin B is a promising natural compound for managing Toll-like receptor-mediated inflammatory disorders.
  • Further research into Sparstolonin B could lead to novel therapeutic strategies for inflammatory diseases.
  • Selective TLR antagonism represents a viable approach for treating inflammatory conditions.